Rare diseases
Investigational molecules
Locations
Back to France1 521 clinical trials in Toulouse, France across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)A study testing duvakitug for patients with moderately to severely active ulcerative colitis
FranceA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
FranceA study testing xanomeline tartrate and trospium chloride for treating agitation in patients with Alzheimer's disease
FranceStudy of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation
FranceStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
FranceStudy of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy
FranceLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
FranceStudy of VENT-03 tablets in adults with active cutaneous lupus erythematosus with or without systemic lupus erythematosus
FranceStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
FranceStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
FranceStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
FranceStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on heart disease treatment, including trials for TTR amyloidosis and prevention of heart failure. Advanced therapeutic approaches using novel compounds like baxdrostat in combination with established medications.
Comprehensive cancer research targeting multiple types of malignancies, including head and neck cancer, gastric cancer, and advanced pancreatic cancer. Novel approaches using targeted therapies and immunotherapy combinations.
Advanced research in neurodegenerative conditions and movement disorders, including studies on frontotemporal dementia, essential tremor, and traumatic brain injury outcomes.
Studies investigating new treatments for inflammatory diseases, including innovative approaches for Crohn's disease, psoriatic arthritis, and myasthenia gravis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
